Enanta Pharmaceuticals ENTA
NASDAQ ENTA
$13.15 +0.51 (+4.07%)
As of: Sep 30, 2026 · 3:56 PM EDT

Enanta Pharmaceuticals (ENTA) Capital Expenditures (2012 - 2026)

Updated

Enanta Pharmaceuticals (ENTA) recorded Capital Expenditures of $7,000 in fiscal Q3 2026 (quarter ended Jun 30, 2026), down 95.5% from $155,000 a year earlier and down 53.3% from the prior quarter.

Analysis

Enanta Pharmaceuticals (ENTA) Capital Expenditures (2012 - 2026) Analysis & Trends

On a TTM basis, Enanta Pharmaceuticals' Capital Expenditures came in at $1.62 million as of Jun 30, 2026, down 92.0% year-over-year; for FY2025 (ended Sep 30, 2025), it came in at $12.9 million, down 28.1% from FY2024.

  • Annual Capital Expenditures has a five-year compound annual growth rate of 54.9% (FY2020 to FY2025).
  • Across earlier fiscal years, Capital Expenditures came in at $17.95 million in FY2024 (+98.1%), $9.06 million in FY2023 (+326.3%), $2.13 million in FY2022 (+183.3%) and $750,000 in FY2021 (-48.1%).
  • The fiscal Q3 2026 figure is the lowest quarterly Capital Expenditures in data going back to fiscal Q3 2012.
  • On a year-over-year basis, Capital Expenditures has declined for five consecutive quarters, with growth averaging 18.8% over the last seven quarters.
  • Peak year-over-year performance for Capital Expenditures in the last five years was growth of 769.4% in fiscal Q1 2023, against a decline of 99.4% in fiscal Q2 2026 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $15,000 (Q2 2026), $143,000 (Q1 2026) and $1.46 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 1.32 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 322.00 Mn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -763.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 140.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 112.20 Mn
10 Enanta Pharmaceuticals 368.08 Mn -359.92 Mn - 7,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7,000.00
Mar 31, 2026 15,000.00
Dec 31, 2025 143,000.00
Sep 30, 2025 1.46 Mn
Jun 30, 2025 155,000.00
Mar 31, 2025 2.54 Mn
Dec 31, 2024 8.75 Mn
Sep 30, 2024 8.95 Mn
Jun 30, 2024 6.54 Mn
Mar 31, 2024 1.67 Mn
Dec 31, 2023 787,000.00
Sep 30, 2023 1.37 Mn
Jun 30, 2023 2.15 Mn
Mar 31, 2023 2.38 Mn
Dec 31, 2022 3.16 Mn
Sep 30, 2022 1.44 Mn
Jun 30, 2022 251,000.00
Mar 31, 2022 74,000.00
Dec 31, 2021 363,000.00
Sep 30, 2021 33,000.00
API Access

Enanta Pharmaceuticals Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ENTA&period=max&api_key=YOUR_API_KEY